There is evidence to suggest that PMP22, the target protein in CMT1A—despite being considered to be expressed selectively in the periphery—shares partial homology with other CNS proteins like the proteolipid protein (PLP) [7]. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.